Scan
To download the app
Download the Beloud app and enjoy reading the latest news, freedom of speech, and connect with the like-minds.
Download on the
App Store
Download on the
Google Play
Continue reading in...
Beloud App
Open
Safari
Continue
Sign in
Saved
Subscription
Settings
For You
Headlines
NewsStand
For You
Headlines
NewsStand
Saved
Light/Dark
Invite friends
Settings
Support
Get the app
Novels
Reading
283
Followers
Follow
Nbcnews
@nbcnews.com
7 hours
Novel climate change lawsuit seeking damages from oil companies heads to Supreme Court
www.nbcnews.com
0
0
0
0
Comments
Seekingalpha
@seekingalpha.com
Yesterday
Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted Therapy for Dermatomyositis
seekingalpha.com
0
0
0
0
Comments
Desmoinesregister
@desmoinesregister.com
3 days
Iowa high school volleyball heads outside at Valley Stadium
www.desmoinesregister.com
0
0
0
0
Comments
Seekingalpha
@seekingalpha.com
3 days
Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted Therapy for Dermatomyositis Transcript
seekingalpha.com
0
0
0
0
Comments
Patch
@patch.com
4 days
Smithtown Teen Writes 2 Novels, Earns Suffolk Distinguished Youth Award
patch.com
0
0
0
0
Comments
ScreenRant
@screenrant.com
4 days
Rebecca Yarros Reveals Stunning Cover For New Fourth Wing Release
screenrant.com
0
0
0
0
Comments
Ctvnews
@kitchener.ctvnews.ca
4 days
Trump tariffs: Canada bolsters defence spending at home
www.ctvnews.ca
0
0
0
0
Comments
Patch
@patch.com
5 days
NY Times Bestselling Author To Speak At South OC Library: What To Know
patch.com
0
0
0
0
Comments
Dexerto
@dexerto.com
5 days
Danganronpa 2×2 is cancelling preorders because it won’t get a physical release for “unavoidable reasons”
www.dexerto.com
0
0
0
0
Comments
Wcfcourier
@wcfcourier.com
5 days
Final Thursday Reading Series returns to Hearst Center
wcfcourier.com
0
0
0
0
Comments
Sign in
Saved
Subscription
Settings
CRM automation
Log In Or Sign Up
Sign Up Now To Get Your Own Personalized Timeline
Continue with Email
By signing up, you agreed to our
Terms of used
and
Privacy policy
, including Cookies use.
Terms of use
Privacy policy
Publishers
Contact
About us
Subscription
CRM automation
© 2022 Safe Apps